Tech Company Financing Transactions
Novalar Pharmaceuticals Funding Round
Novalar Pharmaceuticals, based in San Diego, secured investment capital from New Enterprise Associates, Boston Millennia Partners and Domain Associates.
Transaction Overview
Company Name
Announced On
11/1/2007
Transaction Type
Venture Equity
Amount
Unknown
Round
Series D
Investors
New Enterprise Associates (Lead Investor) (Michael Raab)
Boston Millennia Partners (Robert Jevon)
Domain Associates (Robert More)
Proceeds Purpose
The funds will be used to support Novalar's anticipated U.S. launch of NV-101, a first-in-class, local dental anesthetic reversal agent, as well as the development of other innovative dental pharmaceuticals in the company's pipeline.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
12555 High Bluff Drive 300
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Novalar Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company based in San Diego, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donna Janson
Chief Financial Officer
Robert Stefanovich
Chief Medical Officer
Richard Ghalie
Chief Operating Officer
Laura Navalta
Vice President
Doug Bakan
VP - Sales
Jeffrey Lord
Browse more venture capital transactions:
Prev: 10/31/2007: Tego venture capital transaction
Next: 11/1/2007: Asteres venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs